Brazil Pharmaceuticals

Showing all 16 results

Brazil’s Anvisa : Good Manufacturing Practices (GMP) for Radiopharmaceutical Medicines
$50.00 Add to cart
Brazil’s Anvisa: Classification Criteria and Procedures Of Non-Prescription Medicine Medication
$75.00 Add to cart
Brazil’s Anvisa: Conducting Clinical Trials with Medicines in Brazil
$350.00 Add to cart
Brazil’s Anvisa: Good Clinical Practices for Inspection Procedures of Drug Clinical Trials
$30.00 Add to cart
Brazil’s Anvisa: Good Manufacturing Practice (GMP) for Active Pharmaceutical Ingredients(API)
$400.00 Add to cart
Brazil’s Anvisa: Good Manufacturing Practices (GMP) guidelines
$550.00 Add to cart
CRITERIA FOR CONDUCTING STABILITY STUDIES FOR ACTIVE PHARMACEUTICAL INGREDIENTS AND NON-BIOLOGICAL DRUGS
$300.00 Add to cart
FRAMEWORK FOR PRIORITY IN THE REGISTRATION, POST-REGISTRATION AND PRIOR CONSENT IN DRUG CLINICAL RESEARCH
$30.00 Add to cart
GOOD MANUFACTURING PRACTICES FOR EXPERIMENTAL DRUGS USED IN CLINICAL TRIALS
$150.00 Add to cart
INSPECTION PROCESSES AND REQUIREMENTS TO VERIFY THE GOOD MANUFACTURING PRACTICES OF MANUFACTURERS OF ACTIVE PHARMACEUTICAL INGREDIENTS, HEALTH PRODUCTS OF RISK CLASS III AND IV AND MEDICINES
$400.00 Add to cart
REGISTRATION FOR GENERIC, SIMILAR, SPECIFIC, DYNAMIZED, HERBAL AND BIOLOGIC MEDICINAL PRODUCTS (SIMPLIFIED PROCEDURE)
$50.00 Add to cart
REGISTRATION OF RADIOPHARMACEUTICALS OF MANUFACTURED IN NATIONAL TERRITORY
$30.00 Add to cart
REGISTRATION PROCESS OF BIOLOGICAL PRODUCTS
$300.00 Add to cart
RULES FOR SUBCONTRACTING: PRODUCTION STAGES, CONTROL ANALYSIS FOR QUALITY CONTROL, CONTROL OF TRANSPORT AND STORAGE OF MEDICINES AND BIOLOGICAL PRODUCTS
$50.00 Add to cart
SPECIAL PROCEDURE FOR THE CONSENT OF CLINICAL TRIALS, GOOD MANUFACTURING PRACTICES CERTIFICATION AND NEW DRUG REGISTRATION FOR THE TREATMENT, DIAGNOSIS OR PREVENTION OF RARE DISEASES
$30.00 Add to cart
THE REGISTRATION OF VITAMINS, MINERALS, AMINO ACIDS AND PROTEINS CLASSIFIED AS SPECIFIC MEDICINES FOR ORAL USE
$50.00 Add to cart

North America

Latin AMerica

Europe

Australia

Asia

Brazil’s Anvisa : Good Manufacturing Practices (GMP) for Radiopharmaceutical Medicines

Brazil’s Anvisa: Classification Criteria and Procedures Of Non-Prescription Medicine Medication

Brazil’s Anvisa: Conducting Clinical Trials with Medicines in Brazil

Brazil’s Anvisa: Good Clinical Practices for Inspection Procedures of Drug Clinical Trials

Brazil’s Anvisa: Good Manufacturing Practice (GMP) for Active Pharmaceutical Ingredients(API)

Brazil’s Anvisa: Good Manufacturing Practices (GMP) guidelines

CRITERIA FOR CONDUCTING STABILITY STUDIES FOR ACTIVE PHARMACEUTICAL INGREDIENTS AND NON-BIOLOGICAL DRUGS

FRAMEWORK FOR PRIORITY IN THE REGISTRATION, POST-REGISTRATION AND PRIOR CONSENT IN DRUG CLINICAL RESEARCH

GOOD MANUFACTURING PRACTICES FOR EXPERIMENTAL DRUGS USED IN CLINICAL TRIALS

INSPECTION PROCESSES AND REQUIREMENTS TO VERIFY THE GOOD MANUFACTURING PRACTICES OF MANUFACTURERS OF ACTIVE PHARMACEUTICAL INGREDIENTS, HEALTH PRODUCTS OF RISK CLASS III AND IV AND MEDICINES

REGISTRATION FOR GENERIC, SIMILAR, SPECIFIC, DYNAMIZED, HERBAL AND BIOLOGIC MEDICINAL PRODUCTS (SIMPLIFIED PROCEDURE)

REGISTRATION OF RADIOPHARMACEUTICALS OF MANUFACTURED IN NATIONAL TERRITORY

REGISTRATION PROCESS OF BIOLOGICAL PRODUCTS

RULES FOR SUBCONTRACTING: PRODUCTION STAGES, CONTROL ANALYSIS FOR QUALITY CONTROL, CONTROL OF TRANSPORT AND STORAGE OF MEDICINES AND BIOLOGICAL PRODUCTS

SPECIAL PROCEDURE FOR THE CONSENT OF CLINICAL TRIALS, GOOD MANUFACTURING PRACTICES CERTIFICATION AND NEW DRUG REGISTRATION FOR THE TREATMENT, DIAGNOSIS OR PREVENTION OF RARE DISEASES

THE REGISTRATION OF VITAMINS, MINERALS, AMINO ACIDS AND PROTEINS CLASSIFIED AS SPECIFIC MEDICINES FOR ORAL USE

ABOUT GRP GROUP

GRP Headquarters

Tel : (+1 ) 781 - 672 -4200

Follow GRP on Social Media

GRP Group Offices

USEFUL LINKS